7-[3,5-di(carbazol-9-yl)phenyl]-N,N-diphenyltriphenylen-2-amine
C60H39N3 — CID 88884831
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[3,5-di(carbazol-9-yl)phenyl]-N,N-diphenyltriphenylen-2-amine
7-[3,5-di(carbazol-9-yl)phenyl]-N,N-diphenyltriphenylen-2-amine (PubChem CID 88884831) has the molecular formula C60H39N3 and a molecular weight of 801.99 g/mol. Its IUPAC name is 7-[3,5-di(carbazol-9-yl)phenyl]-N,N-diphenyltriphenylen-2-amine.
Molecular Properties
| Compound Name | 7-[3,5-di(carbazol-9-yl)phenyl]-N,N-diphenyltriphenylen-2-amine |
|---|---|
| PubChem CID | 88884831 |
| Molecular Formula | C60H39N3 |
| Molecular Weight | 801.99 g/mol |
| Exact Mass | 801.31 |
| IUPAC Name | 7-[3,5-di(carbazol-9-yl)phenyl]-N,N-diphenyltriphenylen-2-amine |
| SMILES | c1ccc(N(c2ccccc2)c2ccc3c4ccc(-c5cc(-n6c7ccccc7c7ccccc76)cc(-n6c7ccccc7c7ccccc76)c5)cc4c4ccccc4c3c2)cc1 |
| InChI | InChI=1S/C60H39N3/c1-3-17-42(18-4-1)61(43-19-5-2-6-20-43)44-32-34-50-49-33-31-40(37-55(49)47-21-7-8-22-48(47)56(50)39-44)41-35-45(62-57-27-13-9-23-51(57)52-24-10-14-28-58(52)62)38-46(36-41)63-59-29-15-11-25-53(59)54-26-12-16-30-60(54)63/h1-39H |
| InChIKey | OQNSSRLNBFPDDU-UHFFFAOYSA-N |
| XLogP | 16.48 |
| TPSA | 13.10 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 801.99 |
| LogP ≤ 5 | 16.48 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 88884831 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.